Preserved Sleep for the Same Level of Respiratory Disturbance in Children with Prader-Willi Syndrome.

before-after comparison growth hormone obstructive sleep apnea polysomnography sleep-related breathing disorders

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
13 Sep 2022
Historique:
received: 08 08 2022
revised: 07 09 2022
accepted: 08 09 2022
entrez: 23 9 2022
pubmed: 24 9 2022
medline: 28 9 2022
Statut: epublish

Résumé

Debate remains as to how to balance the use of recombinant human growth hormone (rhGH) as an important treatment in Prader-Willi syndrome (PWS) with its potential role in obstructive sleep apnea. This single-center, retrospective study assessed differences in overnight polysomnography results between children with and without PWS and changes in respiratory parameters before and after the initiation of rhGH treatment in those with PWS. Compared with age-, sex-, and body-mass-index-matched controls (n = 87), children with PWS (n = 29) had longer total sleep time (434 ± 72 vs. 365 ± 116 min; p < 0.01), higher sleep efficiency (86 ± 7 vs. 78 ± 15%; p < 0.05), and lower arousal events (8.1 ± 4.5 vs. 13.0 ± 8.9 events/h; p < 0.05). Mean oxygen saturation was lower in PWS children (94.3 ± 6.0 vs. 96.0 ± 2.0%; p < 0.05), with no other differences in respiratory parameters between groups. Eleven children with PWS (38%) met the criteria for further analyses of the impact of rhGH; polysomnography parameters did not change with treatment. Compared with other children undergoing polysomnography, children with PWS had more favorable markers of sleep continuity and lower oxygen saturation for the same level of respiratory disturbance. rhGH administration was not associated with changes in respiratory parameters in PWS.

Identifiants

pubmed: 36142494
pii: ijms231810580
doi: 10.3390/ijms231810580
pmc: PMC9501212
pii:
doi:

Substances chimiques

Human Growth Hormone 12629-01-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

J Clin Sleep Med. 2019 Mar 15;15(3):437-443
pubmed: 30853051
Acta Paediatr. 2005 Jul;94(7):974-7
pubmed: 16188826
J Endocrinol Invest. 2005 Jun;28(6):554-7
pubmed: 16117198
BMJ Paediatr Open. 2020 Apr 29;4(1):e000630
pubmed: 32411831
Sleep Med. 2006 Dec;7(8):627-33
pubmed: 17023209
J Sleep Res. 2010 Mar;19(1 Pt 2):248-54
pubmed: 19912511
Chest. 1995 Dec;108(6):1627-31
pubmed: 7497773
Nat Genet. 2007 Oct;39(10):1266-72
pubmed: 17893678
J Clin Endocrinol Metab. 2017 May 1;102(5):1702-1711
pubmed: 28323917
Biol Neonate. 2002 Aug;82(2):139-41
pubmed: 12169838
Am J Respir Crit Care Med. 1996 Jan;153(1):283-7
pubmed: 8542130
Pediatr Pulmonol. 2015 Dec;50(12):1346-53
pubmed: 25777054
Arch Dis Child. 2017 Jul;102(7):634-638
pubmed: 28130217
Pediatr Ann. 2013 Oct;42(10):195-9
pubmed: 24126981
Curr Pediatr Rev. 2019;15(4):207-244
pubmed: 31333129
J Clin Endocrinol Metab. 2003 May;88(5):2206-12
pubmed: 12727976
Eur J Pediatr. 2018 Sep;177(9):1367-1370
pubmed: 29318372
J Clin Endocrinol Metab. 2011 Jan;96(1):29-33
pubmed: 20943780
Eur J Pediatr. 1999 Nov;158(11):936-40
pubmed: 10541953
J Paediatr Child Health. 2013 Mar;49(3):238-41
pubmed: 23438058
Sleep Med Rev. 2021 Jun;57:101432
pubmed: 33567377
Clin Endocrinol (Oxf). 2006 Aug;65(2):178-85
pubmed: 16886957
Int J Legal Med. 2005 May;119(3):153-7
pubmed: 15750809
J Clin Endocrinol Metab. 2013 Sep;98(9):E1516-23
pubmed: 23894156
Acta Paediatr. 2012 Jun;101(6):643-8
pubmed: 22385467
J Clin Endocrinol Metab. 2013 Jun;98(6):E1072-87
pubmed: 23543664
J Clin Sleep Med. 2014 Apr 15;10(4):403-9
pubmed: 24733986
J Clin Endocrinol Metab. 2006 Dec;91(12):4911-5
pubmed: 17003096
Am J Med Genet A. 2008 Apr 1;146A(7):881-7
pubmed: 18324685
Am J Med Genet B Neuropsychiatr Genet. 2009 Dec 5;150B(8):1085-99
pubmed: 19199291
J Pediatr. 2013 Feb;162(2):263-8.e1
pubmed: 22947651
Sleep Med. 2019 Feb;54:43-47
pubmed: 30529776
J Clin Neurol. 2022 Mar;18(2):140-151
pubmed: 35274834
Chest. 2014 Nov;146(5):1387-1394
pubmed: 25367475
J Pediatr. 2004 Jan;144(1):129-31
pubmed: 14722532
Am J Med Genet A. 2005 Jul 1;136(1):45-8
pubmed: 15937939
Pediatr Neurol. 2021 Oct;123:30-37
pubmed: 34388423
J Clin Endocrinol Metab. 2006 Feb;91(2):413-7
pubmed: 16317059
Int J Mol Sci. 2022 Jan 10;23(2):
pubmed: 35054894
Sleep. 2017 Dec 1;40(12):
pubmed: 29294134
Clin Neurophysiol. 2001 May;112(5):800-5
pubmed: 11336895
Clin Obes. 2011 Aug;1(4-6):175-83
pubmed: 25585907
J Endocrinol Invest. 2009 Jul;32(7):601-5
pubmed: 19498323
J Clin Sleep Med. 2009 Oct 15;5(5):448-53
pubmed: 19961030
J Pers Med. 2021 Feb 18;11(2):
pubmed: 33670584
Orphanet J Rare Dis. 2019 Nov 4;14(1):238
pubmed: 31684997
Horm Res. 2005;63(1):33-9
pubmed: 15604598
Hum Mol Genet. 2007 Nov 15;16(22):2713-9
pubmed: 17728320

Auteurs

Qiming Tan (Q)

Department of Pediatrics, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB T6G 1C9, Canada.
Women & Children's Health Research Institute, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB T6G 1C9, Canada.

Xiao Tian Tim He (XTT)

Department of Pediatrics, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB T6G 1C9, Canada.

Sabrina Kang (S)

Department of Pediatrics, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB T6G 1C9, Canada.

Andrea M Haqq (AM)

Department of Pediatrics, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB T6G 1C9, Canada.
Women & Children's Health Research Institute, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB T6G 1C9, Canada.
Stollery Children's Hospital, Edmonton, AB T6G 2B7, Canada.

Joanna E MacLean (JE)

Department of Pediatrics, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB T6G 1C9, Canada.
Women & Children's Health Research Institute, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB T6G 1C9, Canada.
Stollery Children's Hospital, Edmonton, AB T6G 2B7, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH